Clinical Trials Directory

Trials / Unknown

UnknownNCT01152164

Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
167 (actual)
Sponsor
Institute of Oncology Ljubljana · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is gathering informations about patients' quality of life after combined modality treatment of rectal cancer to evaluate how combined modality treatment for rectal cancer affects patients' quality of life. The findings of this study may provide us important information that can be used in treatment decision and to develop programs to improve quality of life of patients with rectal cancer.

Detailed description

Over the last two decades, rectal cancer research has lead to better understanding of disease behaviour, resulting in more efficient treatments and higher prevalence of cancer survivors.Due to aggressive therapy, rectal cancer survivors can exhibit late sequelae of treatment, most common being impaired bowel, voiding, sexual malfunctioning and quality of life impairment. In order to determine the impact of rectal cancer and its treatment on patients' quality of life over time, this study will prospectively follow a cohort of patients at specified intervals evaluating their physical symptoms, physical and social functioning and overall quality of life.Medical and sociodemographic factors that might be predictive will be tested.

Conditions

Interventions

TypeNameDescription
BEHAVIORALquestionnairesQuality of life assessment using questionnaires EORTC QLQ C30 and 38 at baseline, one year and two years after the surgery of rectal cancer, treated with preoperative capecitabine based radiochemotherapy

Timeline

Start date
2008-01-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2010-06-29
Last updated
2012-03-26

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT01152164. Inclusion in this directory is not an endorsement.